Proceedings of the PSK Conference (대한약학회:학술대회논문집)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Incidence level of abnormality in creatine phosphokinase by statin

  • Kim, Yoo-Ni (Dept. of Preventive Medicine, Seoul Natl. Univ. College of Medicine) ;
  • Bae, Kyun-Seop (Clinical Trial Center, Seoul Natl. Univ. Hospital) ;
  • Jung, Sun-Hoi (Dept. of Pharmacy, Seoul Natl. Univ. Hospital) ;
  • Lee, Seung-Mi (Dept. of Health Informatics, Yonsei Univ. Graduate School of Public Health) ;
  • Yoon, Kyoung-Eun (Dept. of Health Informatics, Yonsei Univ. Graduate School of Public Health) ;
  • Kim, Hwa-Young (Dept. of Health Informatics, Yonsei Univ. Graduate School of Public Health) ;
  • Chae, Young-Moon (Dept. of Health Informatics, Yonsei Univ. Graduate School of Public Health) ;
  • Park, Byung-Joo (Dept. of Health Informatics, Yonsei Univ. Graduate School of Public Health)
  • Published : 2002.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Creatine phosphokinase (CPK) was a marker in diagnosis of rhabdomyolysis. The CPK abnormality could be induced by intake of HMG CoA reductase inhibitors (statins). The objective of this study was to estimate the incidence rate of CPK abnormality by each statin. (omitted)

Keywords